Sign inCreate Account
Ranbaxy Laboratories on Monday said it has received tentative approval from the United States Food and Drug Administration to manufacture and market anti-hypertension drug Quinapril Hydrochloride in the US.
NEWS
BUSINESS
MOVIES
CRICKET
SPORTS
GET AHEAD
REDIFF MONEY
REDIFF-TV
REDIFF ASTRO